ASX Announcements

Filter by Year: 2018 2017 2016
NOX to support expanded LuPIN study
Appendix 4E and Audited Financial Statements
Nyrada-Key progress with cholesterol-lowering drug candidate
VEYONDA - Registered Trade Mark for NOX66
Change of Director's Interest Notice - GK
Change of Director's Interest Notice - PM
Change of Director's Interest Notice - ID
Appendix 3B
Interim NOX66 Radiotherapy Clinical Data
Appendix 4C- Quarterly report for the quarter ended June 30, 2018

Pages:
1 2 3 4 5 6 Next